Floatz logo

CO-METHYLCOBINAMIDE DIHYDROGEN PHOSPHATE (ESTER) INNER SALT 3'-ESTER WITH 5,6-DIMETHYL-1-.ALPHA.-D-RIBOFURANOSYL-1H-BENZIMIDAZOLE-.KAPPA.N(SIP 3)

Breast Cancer

Peking University Cancer Hospital & InstituteSmall moleculePhase 4 / ApprovedActive
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
59/ 100

Competitive context

890 Active assets in the Breast Cancer cohort.

Asset / SponsorPhaseRating
Lapatinib
University of New Mexico
Phase 3BBB
Darolutamide
Vandana Abramson
Phase 2BBB
Trastuzumab Duocarmazine
Byondis B.V.
Phase 3BB
ERIBULIN MONOMETHANESULFONATE
Henan Cancer Hospital
Phase 4BB
Palbociclib
Hoffmann-La Roche
Phase 4BB

View all 50 →

Same molecule, other indications

CO-METHYLCOBINAMIDE DIHYDROGEN PHOSPHATE (ESTER) INNER SALT 3'-ESTER WITH 5,6-DIMETHYL-1-.ALPHA.-D-RIBOFURANOSYL-1H-BENZIMIDAZOLE-.KAPPA.N(SIP 3) is also rated in:

amyotrophic lateral sclerosisDormant
B
Indicative ·
57 / 100
View asset →
Postherpetic Neuralgia ( PHN )Dormant
D
Indicative ·
30 / 100
View asset →
Early Memory LossDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →